These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 10525381)

  • 21. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
    Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
    Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro.
    Shyu MK; Lin MC; Shih JC; Lee CN; Huang J; Liao CH; Huang IF; Chen HY; Huang MC; Hsieh FJ
    Hum Reprod; 2007 Oct; 22(10):2723-32. PubMed ID: 17720698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions.
    Bamberger AM; Sudahl S; Wagener C; Löning T
    Int J Gynecol Pathol; 2001 Apr; 20(2):160-5. PubMed ID: 11293162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-10 may participate in regulating trophoblast invasion in human placentae throughout gestation.
    Pang ZJ; Zhou JG; Huang LP
    Am J Reprod Immunol; 2008 Jul; 60(1):19-25. PubMed ID: 18593434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 expression in placentas with hydropic change and hydatidiform moles.
    Cheville JC; Robinson RA; Benda JA
    Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
    Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
    Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
    Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
    Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoembryonic antigen and related molecules in normal and transformed trophoblast.
    Vićovac Lj; Bozić M; Bojić-Trbojević Z; Golubović S
    Placenta; 2007; 28(2-3):85-96. PubMed ID: 16574224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
    Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
    Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease.
    Cameron B; Gown AM; Tamimi HK
    Am J Obstet Gynecol; 1994 Jun; 170(6):1616-21; discussion 1621-2. PubMed ID: 7911272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta].
    Ke Y; Lu JH; Yang BL; Guo HQ; Ma QY; Zhu H; Shu HM; Li DJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):311-4. PubMed ID: 16762185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
    Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
    J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester.
    Bjørn SF; Hastrup N; Larsen JF; Lund LR; Pyke C
    Placenta; 2000; 21(2-3):170-6. PubMed ID: 10736239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases.
    Okamoto T; Niu R; Yamada S; Osawa M
    Mol Hum Reprod; 2002 Apr; 8(4):392-8. PubMed ID: 11912288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.